Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Observational × Peritoneal Cancer × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 472 Neoplasms 402 Lung Neoplasms 251 Colorectal Neoplasms 247 Carcinoma, Non-Small-Cell Lung 183 Stomach Neoplasms 177 Carcinoma, Hepatocellular 177 Prostatic Neoplasms 166 Pancreatic Neoplasms 127 Ovarian Neoplasms 113 Uterine Cervical Neoplasms 104 Colonic Neoplasms 104 Rectal Neoplasms 89 Neoplasm Metastasis 88 Urinary Bladder Neoplasms 87 Head and Neck Neoplasms 68 Esophageal Neoplasms 67 Leukemia, Myeloid, Acute 63 Endometrial Neoplasms 63 Brain Neoplasms 61 Precursor Cell Lymphoblastic Leukemia-Lymphoma 60 Disease 59 Recurrence 57 Melanoma 53 Lymphoma 50 Glioma 48 Polycystic Ovary Syndrome 47 Liver Neoplasms 47 Multiple Myeloma 46 Squamous Cell Carcinoma of Head and Neck 41

Interventions

Oxaliplatin 1 Hyperthermic Intraperitoneal Chemotherapy 1 Cytoreduction Surgical Procedures 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04122885 2019-10-10

IMMUNOPAC

University Hospital Tuebingen

Peritoneal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡